Download Newly Diagnosed Patients with Acoustic Neuroma

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
Transcript
Newly diagnosed patients with
Acoustic Neuroma
(Individuals Considering Microsurgery)
Richard J. Wiet, MD FACS
Northwestern & Ear Institute of
Chicago
Acknowledgements :
•
•
•
•
•
Neurosurgeons
Colleagues in Neurotology
Neurological nursing OR
Neuro-anesthesia
Neuro-ICU Nursing
Acoustic Neuromas
• 10% of intra-cranial tumors
• Arise in the balance nerve sheath
• 90% are vestibular schwannoma
• Most grow about 2.0 mm / year
Growth rate of schwannoma
• Probable that most are stable for years, but if
observed for a decade, likely it will grow
• Rapid growth is rare; however, there are
exceptions
• Measure either INTRA-canilicular (small) or the
EXTRA-canilicular (greatest dimension) by
sequential MRI
Newly diagnosed, now what?
• Understanding of Natural History of tumor
– Growth rate
– Exceptions to slow growth - discussion
• Classification of these tumors: Jackler
• Watch for any sign of neurological change
Category or classification
•
•
•
•
Intra-canilicular
Cisternal
Brain stem compressive
Hydrocephalic (may be life threatening)
• Small > 1.0 cm
• Medium 1.0 – 2.5
• Large (giant) 2.5 to 4.0 or larger
Your first visit to physician
• Bring the actual MRI
• Expect a hearing test
• Inquire as to the level of experience—
team & Neuro ICU. Who is in charge?
Warning about rapid growth
• Sudden change in neurological status
– Observation phase & change
– Post radiation---rare
– Intra tumor hemorrhage---very rare
• Pregnant?
• NF-2
• Cystic tumors
2003 MRI
2007 MRI
Conservative posture
• Elder patient with small tumor
• Infirmed health
• Small tumors in middle life and beyond
(50% show little growth 3 years)
• Does not apply to a young NF2 patient
Microsurgery generally
recommended
• Large tumors – young patients
• NF 2 – especially young patients
• Cystic tumors
• Patient’s choice, after fair explanation of
options
• Post radiotherapy failure
• Intra tumor hemorrhage
Where controversy lies
• Small to medium tumor : surgery (cure?)vs
stereotactic radiotherapy (control?)
• Not controversial for Large Brainstem
compressive disease--surgery
• No controversy that long term follow up
needed for both
Types of surgery
• Hearing preservation attempts
– Middle fossa surgery---ideal < 1.0 cm
– Retro sigmoid
• Remainder of surgery
– Translabyrinthine
– Trans otic
Recent Advances in Surgery
•
•
•
•
Endoscopic developments
Lasers developed at MIT
Ultra-sonic aspirators for tumor removal
More sophisticated monitoring
• Studies of combining surgery first,
radiotherapy second—”near total “
Hearing conservation
• ABR
• ENG
• ASSR (research)
• Which nerve is involved?
• Value of the MRI presentation
Types of surgical discussions
•
•
•
•
Total removal & risks
Staged surgery
Subtotal removal : capsule remains
Near total removal < “wafer” remains
• Rate of facial paralysis –goes up in tumors
2.0 cm or larger
Post radiation failures
• Focused stereotactic surgery may fail in 2 - 4%
of patients
• Fractionated vs. single dose
• How is failure defined: 1 mm growth in 2
dimensions, 2 mm in one dimension
beyond initial treatment-(may be reported at 60 months after stereotactic
radiosurgery)
Goals of surgery
• Preservation of life & with a reasonable
quality of life
• Preservation of the facial nerve—cannot
be guaranteed
• Preservation of hearing---most difficult
What happens when tumor surgery
is not centralized ?
• CENTALIZED
– Mortality rate : < 1%
– Rate of F. N. paralysis, and CSF leak low
• NOT CENTRALIZED
–
–
–
–
Mortality rates of 8.5%
1/3 patients have permanent paralysis
36% CSF leak
Residual tumor
Danish study
Recommendations
• Based on age alone: first option is Surgery for those
less than 55 years old; VS. second option :
Stereotactic radiation
• Based on size: first option is Surgery if more than
2.5 cm in greatest dimension
1.1 to 2.5 cm: Surgery or Stereotactic
• Based on deficit: if neurological deficits are present,
consider Surgery
• Not NU policy
• Based on 25+ years experience
ANA 2007-2008 Patient Survey
• Symptoms related to acoustic neuroma
– 88% of respondents experienced single-sided
hearing loss or deafness
– 73% experienced tinnitus
– 59% experienced vertigo
ANA 2007-2008 Patient Survey
• Surgical approach most frequently chosen option
– Translabyrinthine approach for 33% of respondents
– Retrosigmoid approach for 17% of respondents
– Middle fossa approach for 10% of respondents
• Radiosurgery/Radiotherapy
– Chosen by 20% of respondents in 2007-2008 survey
compared to 5% in the 1998 survey
• Observation
– Chosen by 20% of respondents in 2007-2008 survey
compared to 4% in the 1998 survey
Criteria to consider change
(from observation) :
• Tumor growth of more than 2mm / year
• Tumor size > 25% from prior scan
• Progressive hearing loss, severe
imbalance or progression in facial nerve
symptoms
What I have learned
• Never regretted being conservative with
very small tumors (false + MRI’s)
• Learned most from my complications, how
to avoid them in future
• There is room for all 3 areas of
management
Summary
• Decision about surgery is a personal one
made between patient and physician
• Multiple factors enter into the equation
• It should be a careful decision, with an
analysis of RISK & EXPERIENCE &
PATIENT PREFERENCE